Congruence Therapeutics

Home - Congruence

Montreal, Canada · Founded 2019 · $137.0M raised

Headquarters
Montreal
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$137.0M
Last Round
$40.0M Series BMar 2026
Rounds
4

About

Congruence Therapeutics is a Montreal-based drug discovery company harnessing protein dynamics, biophysics, machine learning, and computational chemistry to design small-molecule correctors for diseases caused by protein misfolding. Its proprietary Revenir platform models the full conformational ensemble of target proteins.

Summary

Congruence Therapeutics is a Biotech company based in Montreal, Canada, founded in 2019. It has raised $137.0M in total across 4 rounds, most recently a $40.0M Series B round in Mar 2026. Investors include Lumira Ventures, Amplitude Ventures and Fonds de solidarité FTQ.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BMar 2026
$40.0M

Sign up to see all 4 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Congruence Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/congruence-therapeutics"><img src="https://indexed.vc/api/badge/company/congruence-therapeutics" alt="Congruence Therapeutics on Indexed.vc" width="260" height="76" /></a>